Advances for the Development of In Vitro Immunosensors for Multiple Sclerosis Diagnosis

The diagnosis of diseases based on immunosensors have been objective of research in the last years, providing an improvement for a rapid detection, high sensitivity, precision, accuracy, specificity and resolution. Areas of progress such as analytical technologies, interpretation and standardization...

Full description

Saved in:
Bibliographic Details
Published in:Biochip journal 2021, 15(3), , pp.205-215
Main Authors: Guerrero, Jorge M., Aguirre, Francisco S., Mota, María L., Carrillo, Amanda
Format: Article
Language:English
Subjects:
Biomarkers
Biomedical Engineering and Bioengineering
Biosensors
Biotechnology
Brain research
Cerebrospinal fluid
Chemistry
Chemistry and Materials Science
Cytokines
Developing countries
Diagnosis
Diagnostic systems
Disease
Enzyme-linked immunosorbent assay
Immune system
Immunosensors
In vitro methods and tests
LDCs
Magnetic resonance imaging
Medical research
Multiple sclerosis
Nervous system
Nervous system diseases
Patients
R&D
Research & development
Review Article
Standardization
Technological change
Vital signs
생물공학
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The diagnosis of diseases based on immunosensors have been objective of research in the last years, providing an improvement for a rapid detection, high sensitivity, precision, accuracy, specificity and resolution. Areas of progress such as analytical technologies, interpretation and standardization has been done for common biomarkers. However, years of research and development of a functional immunosensor with an unusual biomarker require further investigation to be optimized in any aspect. Recent development of biosensors to diagnose nervous system diseases, such as immunosensors for multiple sclerosis, has been the object of study in the past 10 years to improve common in vitro diagnostic methods such as enzyme-linked immunosorbent assays (ELISA) on cerebrospinal fluid (CSF), showing a big opportunity for further diagnostic optimization. The aim of this review is to show a report on the development of in vitro immunosensors for multiple sclerosis diagnosis until today, with the particular focus on monitoring analyte concentration levels on cerebrospinal fluid and serum as a contribution and improvement to current diagnostic methods.
ISSN:1976-0280
2092-7843
DOI:10.1007/s13206-021-00018-z